Pet成像
配体(生物化学)
核医学
正电子发射断层摄影术
分子成像
医学
产量(工程)
显像剂
化学
癌症影像学
临床前研究
比活度
临床前影像学
生物医学工程
癌症研究
代谢稳定性
作者
Meilian Zhang,Ye Dong,Chunwei Mo,Zihao Chen,Yanjiang Han,Meng Wang,Haoran Liang,Yongshuai Qi,Yun Zhu,Ganghua Tang,Baomin Xi,Penghui Sun
标识
DOI:10.1021/acsmedchemlett.5c00448
摘要
PD-L1 (programmed death ligand 1), the primary ligand of PD-1 (programmed death 1), is widely expressed across various tumor types. In this study, we developed a novel PET probe, [ 18 F]AlF-Asp 2 -TPP-1, for noninvasive imaging of PD-L1 expression. The probe was synthesized with a radiochemical yield of 13.7%, high radiochemical purity (>95%), and a molar activity exceeding 2.4 GBq/μmol. Stability assays confirmed excellent stability both in vitro and in vivo . Dynamic PET imaging over 90 min revealed rapid tracer accumulation in tumors and other organs within 15 min postinjection. Tumor uptake was 2.48 ± 0.05% ID/g, 1.81 ± 0.20% ID/g, and 0.96 ± 0.09% ID/g at 30, 60, and 90 min, respectively. Collectively, these results suggest that [ 18 F]AlF-Asp 2 -TPP-1 is a promising PET imaging agent for monitoring PD-L1 expression in tumors and may serve as a valuable tool for guiding PD-L1-targeted immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI